The Human Proteome is nearly fully mapped and will provide a knowledge base to accelerate our understanding of how proteins and protein networks can affect human health and disease.
Introduction: goals and progress of iMOP
The human proteome project (HPP) was successful in achieving significant advances in coverage and detection of human proteins including the innumerable proteoforms generated from the restricted genetically encoded sequences by means of posttranslational modifications. This steady increase in knowledge is an essential aspect in our understanding of how biological mechanisms supports health and disease in the human organism. Achieving the first draft of a human proteome was made possible by organising the HPP into work domains which focused on the specific organs and cell types of the human body 1 . This approach not only increased the protein coverage of the complete human proteome, but also provided steady progress to explain fundamental knowledge of organ functions in health and disease 2 .
In recent years, it has become clear that only studying the human organism only presents a fraction of our understanding of human health and physiology 3 . Since humans are in constant interaction with their environment, both inorganic and living, we can no longer neglect organisms and species for which human life, health and disease depends. A fact highlighted by the coevolution of humans with their surrounding living environments 4, 5 . While such analyses should include obvious organisms such as pathogens, it also needs to encompass species that are responsible for our food such as crops and farm animals 6 , as well as the countless symbiotic microorganisms associated with human organs 7 . We now have evidence that symbiotic microbes are involved in operations as diverse as nutrient uptake, biosynthesis, immune response, cognition, tissue development, and cancer [8] [9] [10] [11] .
From both practical and ethical points of view, many studies aimed at exploring human disease are unable to be performed on human subjects. This can range from the inability to collect samples from vital organs, due to experiments that require genetic modifications, issues related to sampling over entire life spans or even long term sampling. Sampling over extended periods is essential to describe mechanisms involved in aging or how specific nutrients affect onset and progression of specific diseases like cancer, autoimmunity, and food allergies. For such studies, model organisms have been and are still essential to achieve insight into the mechanisms of human health and disease 12 .
The iMOP initiative was launched in 2011 13 , with the aim to enforce focus on non-human proteome research, and to bring awareness of the need for integrated multi-organism research within the clinically oriented human proteomics community 14 . The need to establish iMOP was based on a recognition that progress in understanding human biology and health is hampered by a relatively slow progress in proteome research on the many non-human species on which all human life and health depends 15 A major goal for the iMOP initiative is to harmonize technologies across the species-oriented communities. Since proteome methods will often require modification for each species studied, we aim to alleviate the efforts a new species must undergo to provide data that is compatible with human centric proteomics. Many of these approaches were developed through HUPO and include data representation standards 18 , analysis of mass spectrometry data (CompMS) and public data repositories and exchanges 19 all of which would enable the direct integration of human and non-human proteomics data which is essential to enable an understanding of their interaction 13, 14, 20 .
Over the past 5 years, the iMOP initiative has organized workshops and parallel sessions within the framework of the annual HUPO congress 21 , and contributed to shaping a biology and disease driven HPP pillar. We have connected research groups across multiple speciesoriented proteome communities, including those with focus on classic and new model organisms; on microbial proteomes; and brought together research communities that have individually worked with specific agricultural species and within environmental biology [22] [23] [24] [25] [26] [27] [28] [29] .
This cross-species connectivity has been a successful action since these research domains share many of the same daily challenges of developing technologies within relatively small and scattered research domains.
To progress with the goals of iMOP we need a closer involvement from the larger HUPO community to address the challenges shared across the multiple non-human proteome communities. The most important challenges are i) a severe lack of funding for fundamental research on non-human biology research domains; ii) lack of funds hampers progress of research and technology development (e.g. mass spectrometry and bioinformatics) for many species; iii) small research groups in non-human fields results in a limited number of scientists joining HUPO and engaging with the iMOP community. These problems have been further compounded since research areas within the iMOP frame are spread across several overlapping initiatives such as those focussed on microbes, food and nutrition 30 or disease, which collectively support many non-human systems in their focus.
Five years after the establishment of iMOP, it is timely to discuss the need and the progress of the original iMOP objectives and examine whether the iMOP initiative would be better integrated into other HUPO subdivisions such as the Biology/Disease component of HPP (B/D-HPP) 31 . This status paper presents views from those working in non-human proteomics and their efforts to unite biological disciplines across this field. We highlight some of the roadblocks that have contributed to a relatively slow progress of proteome research within fields of basic biology, and highlight the many ways these fields and proteome research are essential to progress research that supports human life and health. With these views, we also hope to invite the broader HUPO community into the discussion of how multi-species proteomes can improve the human proteome research field, to deliver solutions to societal challenging and to human life and health on a global scale, which indeed are the long-term goals of HPP.
Proteomes from biology -what is the value for human proteomics?
The value of model organisms for advancing biomedical research has a long history with such systems having many advantages 12 . Some obvious advantages are that they can be cultivated under defined conditions, can be genetically modified for directed functional studies and many have short life cycles. These and many other factors make them valuable tools to study biological situations in more detail than it would be possible with humans. This holds true for many biological and biochemical experiments and in general also for proteomic studies 32 .
Here we outline examples highlighting how research on model organisms can support the objectives of the B/D-HPP initiative.
An area where a direct interaction between humans and non-human proteomics often occurs are the fields of infection diseases and inflammation. While both the genetic and proteomic background of the host are important, it is equally important to consider this information for the microorganism. During infections, the proteomic repertoire of the infectant can vary from proteases that aid the manipulation of a hosts defense 33 to mechanisms that enable it to subvert the hosts biology for its own purpose 34 . Thus, a detailed knowledge of the functional potential of a microorganism and virus is essential to understand human disease and the associated defense mechanisms to enable the development of therapeutic options.
In recent years, there has been a steady increase in knowledge around how human life and wellbeing are dependent on microorganisms 3 . Complex microbial communities are found throughout the human body from our skin to our intestinal tracts 35 . The knowledge about the fine regulation of these populations, the regulation of their interaction with the human host by exchange of molecular information and, in case of diseases, the role both of host and microbial factors leading to the disturbance of the balance are key for precision medicine in the future. For example, the development of inflammatory bowel disease is not only attributable to human genetic factors but is also triggered by the composition and metabolic activity of the gut microbiome 36 . Understanding the complex mechanisms of the development of such diseases cannot be achieved by conducting research on humans, organs or cell cultures alone as it also requires tremendous efforts to also analyze the microbiota. Thus, other aspects that affect microbiomes, such as nutrition and lifestyle (e.g. smoking), also need to be considered. Agriculture resources was spent on agriculturally important animals 42 . Not much is likely to change in the short term since there has been a stagnation in agricultural research funding by the U.S. government over the past few decades and a shift to the private sector 43 .
Understandably industry-based research will likely focus on applied outcomes, however with stagnating funds, research that leads to fundamental understandings of processes such as host response to pathogens is likely to be undertaken by fewer research groups.
Meeting the need for new antibiotics and reducing the use of current antibiotics requires new lines of research, including fundamental research into zoonosis, studies of pathogen biology and comparative infection studies of humans and animals. A major challenge for innovations in antibiotic therapy is that gut health depends on complex interactions of both human/animal genetics and environmental factors like food and gut bacteria. Specific animal models to allow studies of animal health and host-pathogen cross-talk at the molecular levels are needed for directing the design of novel therapeutics, but such animal models are rare, costly, and challenging to study. Recent work with both humans and pigs, have demonstrated that genevariants can protect against E. coli infections by determining the structure of glycan receptors to control bacterial colonization of the gut, but little is known about the specific interactions between glycans and bacteria 27 . Clearly, proteome research of these non-human species is needed, in part to study specific host-pathogen crosstalk at the molecular level, but also for making available panels of accurate health measures for monitoring the health state of relevant animal models and for delivering proof of concept when new drugs, or alternatives like pre-and pro-biotics are being tested for their efficiency in protecting both animals and humans against pathogens.
Farm animal proteomes, and the many ways it links to human health.
As discussed above, industrial farm animal production presents challenges to the health of both farm animals and humans. Thus, building fundamental knowledge of farm animal biology is essential to provide new insights into human health. Here we reflect on some of the direct links between human and animal health, and highlight how farm animal proteome resources are essential for progress towards sustainable farm animal production methods that will benefit of human health.
i. Sustainable food production
Meat, milk and eggs represent a major protein source of the human diet, both in high meat consuming western societies and throughout the developing world where milk and eggs are fundamental to a healthy diet 44 . Modern farm animal biology is determined by genetic selection. Industrialized breeding strategies has been very successful in increasing the productivity of farm animals, but is also responsible for the collateral decline of animal health, animal welfare and food safety 45 . For example, the feed conversion rate of the Danish Landrace pigs, and likewise, the average milk yield of Holstein cows, has been approximately doubled since 1950, by genetic selection of traits that regulate metabolism and growth 46, 47 .
However, since biochemical pathways of metabolism and immunity are closely connected, the past few decades of genomic selection strategies have narrowly targeted productivity traits.
These include factors like weight gain and milk yield, which are easily monitored and correlated to gene variants available in the breeding stock. However, such a selection process will also affect the host response pathways that allow the animal to fight pathogens 48 . The unintended side-effects of intensive breeding today are clear, with unacceptably high animal mortality rates and a reliance on antibiotics 49, 50 . Current farm animal proteome research has mainly been aimed at marker discovery used to monitor early onset of diseases 51 , but more research is needed to enable advanced techniques such as selected reaction monitoring (SRM)
to deliver breakthroughs at the scale available for human studies 52 . SRM based monitoring of animal health could support a more sustainable genetic selection of future livestock, to achieve animals with a robust balance between productivity and health traits. An application for SRM based monitoring of bovine host response lies in the potential for routine daily monitoring of an animal's immune response to pathogens by linking health markers to daily milking as has been done for genetic markers 53 . Such an approach could support a rebalancing of cow genetics, to achieve a more reasonable trade-off between productivity and health in future milk breeds.
ii. Zoonosis
Over 60 % of all human pathogens originate from animals and while some instances are highly publicized such as SARS and H5N1, the area is largely neglected 54 . As discussed above, comparative studies between humans and animals are essential to deliver the best possible measures to control infectious diseases.
iii. The decline of antibiotic efficiency
The speed of AMR is exacerbated by the massive amounts of antibiotics needed to maintain industrial production of farm animals 55 . As discussed above, industrialized animal farming, based on intensive genetic selection, which together with very large populations and high animal density, has set the stage for accelerated outbreak of infectious diseases, which require frequent use of antibiotics. The current lack of monitoring of both pathogens and an individual animal's health state leads to administration of antibiotics often with very little gain 41 . For this reason, better monitoring of pathogens, virulence factors and animal health states need to be developed for species-specific proteome based monitoring methods.
iv. The role of farm animals as model organisms
The value of farm animals as model organisms for human disease is underappreciated despite well-established examples such as pig models, which better reflect human metabolism and neurology than rodent models 56 . However, new gene-editing methods like CRISPR could advance farm animal research by making available new and precisely designed animal models allowing fundamental research and support high precision breeding for health traits in farm animals 57 . For farm animal and crop sciences, the new era of high precision gene editing is of particular interest, because in contrast to existing genetics technologies, a CRISPR based approach promises precise optimization of gene variants without the unintended editing of collateral gene positions. This was recently demonstrated by a high precision knock in of a bovine macrophage protein variant, which improved the animal's resistance to respiratory infections 58 . However, new breeds and gene variant animals must be evaluated by thorough phenotypic studies to evaluate effects to their health, and for their environmental impact, and for this, the application of proteome markers for health (e.g. inflammation markers) are essential, as discussed above.
Can advances in crop research and proteomics enable us to feed the world?
Securing crop production under challenging environments to meet future demand depends on innovations in all layers of plant research, breeding and agronomy. Estimates indicate that crop production must double by 2050 to meet global demand 59 . Our capacity to significantly increase production will severely hampered by our need to use marginal lands 60 and by the compounding effects of changing climate 61 . Triticum aestivum (wheat). In this section, we will briefly explore the extent to which wheat proteomics can assist in the future development of one of the worlds most important food crops.
Wheat is grown on more land than any other global crop with over 700 million tonnes produced annually, providing ~20% of daily calories and protein for over 60% of the world's population. Analysis of the bread wheat genome is complicated by the fact that it is hexaploid having originated from three diploid donors. This has made sequencing its genome extremely difficult and only recently has a reference assembly been made available using the Chinese spring cultivar in combination with data from 18 other cultivars 63 . This lack of a highly refined and cohesive genetic resource has greatly limited proteomic studies seeking to map genetic markers and QTLs. However, now with a sequences genome, proteomics will be an essential tool to enable the rapid interpretation of the hexaploid genome as between 80% to 90% is repetitive sequences and these must be characterised a functional or non furnctional genes 63 . Most previous proteomic surveys conducted in wheat have examined responses to stress targeting the discovery of new regulators and mechanisms 64, 65 . More recently, an effort was made to better relate emerging genomic resources with proteomics through the development of a proteo-genomic map of wheat 66 . This resource enables the interpretations of the complex ORFeome as a result of the hexaploidy genome, as one can quickly assess which isoforms of a particular protein are expressed. This is particularly important as many enzymes and metabolic pathways were first characterized in model plants or plants with less complicated genomes than those in the Poaceae. This information can be used to develop SRM transitions to discriminate the between isoforms as a result of duplication events. For example, the first step of fatty acid synthesis in plants is carried out by acetyl-CoA carboxylase and in Arabidopsis this is carried out by a four subunit heteromeric >650kDa membrane associated complex in the plastid and two isoforms of a >500kDa homodimeric complex outside the plastid. In contrast, in wheat only the >500kDa homodimeric complex is present and the complex hybridization history of wheat has resulted in 15 isoforms of this enzyme with widely different expression patterns.
Thus, while there been clear delays in enabling proteomics to be used in many of the most important global crop species, the recent availability of an assembled genomes, modern mass spectrometers and their utilization in generating resources such as the wheat proteo-genomic map are indicative of pipelines initially developed for model organisms. Consequently, it is likely that proteomics will start to play a larger role in molecular breeding programs in crops such as wheat and play an important role in securing global food supplies.
Conclusion
• We are not alone: Human health from the OneHealth perspective. We have above discussed the importance of the non-human proteomes and how these directly link to HPP and human health.
• We suggest a need for a community driven building a MOPP (Multi Organism Proteome Project), to meet some of the needs suggested above.
• The MOPP should gain from the experience harvested in the HPP.
• How can the current HPP support by making MOPP progress at the same priority and progress as the currently much flagged HPP.
• How can iMOP help to re-balance research progress in the relevant MOP fields (future plans, goals, and milestones for your initiative, and the development of a list of priority).
• Most importantly: How can we reach the non-proteome but species oriented communities, to have their support?
• The HUPO has the power to make also non-human proteome development at priority. In fact, only the (relatively) well-funded human field has the power to drive this field
